Testing effectiveness (Phase 2)Ended earlyNCT03724253
What this trial is testing
[68Ga]-NeoBOMB1 Imaging in Patients With Malignancies Known to Overexpress Gastrin Releasing Peptide Receptor (GRPR)
Who this might be right for
Breast CancerProstate CancerColorectal Cancer+2 more
Advanced Accelerator Applications 19